Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Kimura

Showing results (1-10 of 1,248) with videos related to

Pageof 125
Sort By:
Nihon Jinzo Gakkai Shi|September 22, 2015
[CKD management from the viewpoint of the pharmacist]Takeshi Kimura
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 7, 2017
Endeavours to define optimal antithrombotic therapy after percutaneous coronary interventionTakeshi Kimura
Asiaintervention|December 9, 2022
Thoughts on secondary prevention after percutaneous coronary intervention in JapanTakeshi Kimura
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|May 10, 2002
[Basic knowledge of compost]Takeshi Kimura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, EBM: 2) Pursuit for establishing evidence-based medicine in the field of cardiovascular disease in Japan]Takeshi Kimura
JACC. Cardiovascular Interventions|February 8, 2018
What Have We Learned From the ABSORB Trials?Takeshi Kimura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 26, 2011
[Clinical study from Japan and its reflections: j-Cypher Registry]Takeshi Kimura
Lancet (London, England)|December 6, 2017
MiStent: just another example of non-inferiority?Takeshi Kimura
Lancet (London, England)|March 5, 2019
Can ultra-thin strut drug-eluting stents improve outcomes?Takeshi Kimura
JACC. Cardiovascular Interventions|September 5, 2016
Future Research Perspective to Improve Outcomes of Bifurcation 2-StentingTakeshi Kimura
Pageof 125

Showing results (1-10 of 1,248) with videos related to

Sort By:
Pageof 125
Nihon Jinzo Gakkai Shi|September 22, 2015
[CKD management from the viewpoint of the pharmacist]Takeshi Kimura
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 7, 2017
Endeavours to define optimal antithrombotic therapy after percutaneous coronary interventionTakeshi Kimura
Asiaintervention|December 9, 2022
Thoughts on secondary prevention after percutaneous coronary intervention in JapanTakeshi Kimura
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|May 10, 2002
[Basic knowledge of compost]Takeshi Kimura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, EBM: 2) Pursuit for establishing evidence-based medicine in the field of cardiovascular disease in Japan]Takeshi Kimura
JACC. Cardiovascular Interventions|February 8, 2018
What Have We Learned From the ABSORB Trials?Takeshi Kimura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 26, 2011
[Clinical study from Japan and its reflections: j-Cypher Registry]Takeshi Kimura
Lancet (London, England)|December 6, 2017
MiStent: just another example of non-inferiority?Takeshi Kimura
Lancet (London, England)|March 5, 2019
Can ultra-thin strut drug-eluting stents improve outcomes?Takeshi Kimura
JACC. Cardiovascular Interventions|September 5, 2016
Future Research Perspective to Improve Outcomes of Bifurcation 2-StentingTakeshi Kimura
Pageof 125